-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*Clinical information for medical professionals only, reachable in 1s ▎Clinical question: Does the treatment and isolation status of inflammatory arthritis (IA) patients affect the risk of adverse COVID-19 outcomes? Screenshot of the literature▎Study protocol: This population-based retrospective cohort study used electronically linked anonymized health data from the SAIL database, including primary/secondary care, rheumatology, ONS mortality, and the COVID-19 trial da.
The study consisted of patients who were ≥18 years of age between March 2020 and May 2021, tested positive for COVID-19, and had a READ Codes history of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylit.
▎Main findings: A total of 1,966 IA patients and 166,602 tested positive for COVID-1The incidence of IA patients was 5% (1966/56914) compared to 6% (166602/2760442) in the general population, (difference: 5%, 95% CI 4%-7%, p=<00
Adjusted Cox proportional hazards model showed that IA was not associated with higher mortality (HR: 56, 95%CI 18-64, p=28
Significant risk factors included isolation (HR: 52, 95%CI 40-64, p=<001), history of infection prior to admission to hospital (HR: 20, 95%CI 12-28, p=<001), the previous History of hospital admissions during the year (HR: 34, 95%CI 25-44, p=<001) and use of glucocorticoids (HR: 17, 95%CI 09-25, p=<00
▎Deficiencies and Outlook: The low incidence of COVID-19 in IA patients may be due to isolati.
IA was not associated with increased mortality after contracting COVID-19; rather, having susceptibility (isolation), complications, and other factors were associated with increased ri.
From these key risk factors, it can be determined that COVID-19 brings greater hidden dangers to IA patients, and IA patients are advised to take isolation measures during the high social epidemic of COVID-1The assistant of the top journals of the clinical literature is online👇 Scan the QR code below the QR code to jump to the H5 page of "Top Journal Essentials"Click "Download Now"Open the Doctor Station App and click the columnUse the clinical medication Find the "Top Issues Essentials" follow column and subscribe to the column, and read a new top issue every day! Download the Doctor Station App and subscribe anytime, anywhere~
The study consisted of patients who were ≥18 years of age between March 2020 and May 2021, tested positive for COVID-19, and had a READ Codes history of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylit.
▎Main findings: A total of 1,966 IA patients and 166,602 tested positive for COVID-1The incidence of IA patients was 5% (1966/56914) compared to 6% (166602/2760442) in the general population, (difference: 5%, 95% CI 4%-7%, p=<00
Adjusted Cox proportional hazards model showed that IA was not associated with higher mortality (HR: 56, 95%CI 18-64, p=28
Significant risk factors included isolation (HR: 52, 95%CI 40-64, p=<001), history of infection prior to admission to hospital (HR: 20, 95%CI 12-28, p=<001), the previous History of hospital admissions during the year (HR: 34, 95%CI 25-44, p=<001) and use of glucocorticoids (HR: 17, 95%CI 09-25, p=<00
▎Deficiencies and Outlook: The low incidence of COVID-19 in IA patients may be due to isolati.
IA was not associated with increased mortality after contracting COVID-19; rather, having susceptibility (isolation), complications, and other factors were associated with increased ri.
From these key risk factors, it can be determined that COVID-19 brings greater hidden dangers to IA patients, and IA patients are advised to take isolation measures during the high social epidemic of COVID-1The assistant of the top journals of the clinical literature is online👇 Scan the QR code below the QR code to jump to the H5 page of "Top Journal Essentials"Click "Download Now"Open the Doctor Station App and click the columnUse the clinical medication Find the "Top Issues Essentials" follow column and subscribe to the column, and read a new top issue every day! Download the Doctor Station App and subscribe anytime, anywhere~
